I was tested +ve on 5/6 and started Paxlovid treatment from that day to 5/10. Symptoms subsided 2 days after starting and tested negative yesterday (5/13). But today's test came out +ve again; COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I was tested +ve on 5/6 and started Paxlovid treatment from that day to 5/10. Symptoms subsided 2 days after starting and tested negative yesterday (5/13). But today's test came out +ve again) and COVID-19 (COVID-19) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058F, 030L20A and 015M20A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Hypertension. Concomitant products included PARACETAMOL, PHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE (FLU COLD & SORE THROAT) from 05-May-2022 to 14-May-2022 and LORATADINE from 01-May-2022 to 14-May-2022 for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021 at 11:00 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-May-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (COVID-19). On 14-May-2022, the patient experienced COVID-19 (I was tested +ve on 5/6 and started Paxlovid treatment from that day to 5/10. Symptoms subsided 2 days after starting and tested negative yesterday (5/13). But today's test came out +ve again). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 06-May-2022 to 11-May-2022 for COVID-19 treatment, at a dose of 1 UNK. At the time of the report, COVID-19 (I was tested +ve on 5/6 and started Paxlovid treatment from that day to 5/10. Symptoms subsided 2 days after starting and tested negative yesterday (5/13). But today's test came out +ve again) and COVID-19 (COVID-19) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-May-2022, SARS-CoV-2 test positive: positive (Positive) Positive. On 13-May-2022, SARS-CoV-2 test positive: negative (Negative) Negative. On 14-May-2022, SARS-CoV-2 test positive: positive (Positive) Positive.         The patient race is (EXACT).  Company comment: This spontaneous case concerns a 69-year-old female patient with no relevant medical history who experienced the unexpected non serious AESIs of COVID 19 and COVID 19(COVID 19 reinfection) approximately 6 months after the administration of third dose of mRNA-1273 vaccine. Patient tested positive for COVID 19 on 06-May and started NIRMATRELVIR, RITONAVIR (Paxlovid) treatment from that day to 10-May. Symptoms subsided 2 days after starting treatment and patient tested negative on 13-May. Patient tested positive for COVID 19 on 14-May with symptoms of itchy throat, cough and watery phlegm. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a 69-year-old female patient with no relevant medical history who experienced the unexpected non serious AESIs of COVID 19 and COVID 19(COVID 19 reinfection) approximately 6 months after the administration of third dose of mRNA-1273 vaccine. Patient tested positive for COVID 19 on 06-May and started NIRMATRELVIR, RITONAVIR (Paxlovid) treatment from that day to 10-May. Symptoms subsided 2 days after starting treatment and patient tested negative on 13-May. Patient tested positive for COVID 19 on 14-May with symptoms of itchy throat, cough and watery phlegm. The benefit-risk relationship of mRNA-1273 is not affected by this report.